...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Zenith Epigenetics and Newsoara Announce Initiation of a Randomized Phase 2b Metastatic Castration-Resistant Prostate Cancer Study

Zenith Epigenetics and Newsoara Announce Initiation of a Randomized Phase 2b Metastatic Castration-Resistant Prostate Cancer Study

posted on Sep 24, 2021 09:35AM

https://www.marketscreener.com/quote/stock/RESVERLOGIX-CORP-1411552/news/Zenith-Epigenetics-and-Newsoara-Announce-Initiation-of-a-Randomized-Phase-2b-Metastatic-Castration-R-36489470/

Share
New Message
Please login to post a reply